Cargando…

β(1)-Blockers Enhance Inotropy of Endogenous Catecholamines in Chronic Heart Failure

Although β(1)-blockers impressively reduce mortality in chronic heart failure (CHF), there are concerns about negative inotropic effects and worsening of hemodynamics in acute decompensated heart failure. May receptor theory dispel these concerns and confirm clinical practice to use β(1)-blockers? I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feuerstein, Thomas J., Schlicker, Eberhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220816/ https://www.ncbi.nlm.nih.gov/pubmed/34179127 http://dx.doi.org/10.3389/fcvm.2021.639562

Ejemplares similares

Non-withdrawal of beta blockers in acute decompensated chronic and de novo heart failure with reduced ejection fraction in a prospective multicentre study of patients with acute heart failure in the Middle East
por: Abi Khalil, Charbel, et al.
Publicado: (2017)

Beta-Blocker Use in Older Hospitalized Patients Affected by Heart Failure and Chronic Obstructive Pulmonary Disease: An Italian Survey From the REPOSI Register
por: Arcoraci, Vincenzo, et al.
Publicado: (2022)

Catecholamine-Induced Secondary Takotsubo Syndrome in Children With Severe Enterovirus 71 Infection and Acute Heart Failure: A 20-year Experience of a Single Institute
por: Jan, Sheng-Ling, et al.
Publicado: (2021)

Why has positive inotropy failed in chronic heart failure? Lessons from prior inotrope trials
por: Ahmad, Tariq, et al.
Publicado: (2019)

Beta-blocker management in patients admitted for acute heart failure and reduced ejection fraction: a review and expert consensus opinion
por: Schurtz, Guillaume, et al.
Publicado: (2023)

Association Between Early Oral β-Blocker Therapy and In-Hospital Outcomes in Patients With ST-Elevation Myocardial Infarction With Mild-Moderate Heart Failure: Findings From the CCC-ACS Project
por: Wang, Miao, et al.
Publicado: (2022)

Estrogen Protects Vasomotor Functions in Rats During Catecholamine Stress
por: Zhang, Lin, et al.
Publicado: (2021)

In-hospital Heart Rate Reduction With Beta Blockers and Ivabradine Early After Recovery in Patients With Acute Decompensated Heart Failure Reduces Short-Term Mortality and Rehospitalization
por: Faragli, Alessandro, et al.
Publicado: (2021)

Correlations between serum laminin level and severity of heart failure in patients with chronic heart failure
por: Xie, Ling, et al.
Publicado: (2023)

Isoproterenol-Induced Cardiomyopathy Recovery Intervention: Amlexanox and Forskolin Enhances the Resolution of Catecholamine Stress-Induced Maladaptive Myocardial Remodeling
por: Adzika, Gabriel Komla, et al.
Publicado: (2021)

Cardiac BIN1 Replacement Therapy Ameliorates Inotropy and Lusitropy in Heart Failure by Regulating Calcium Handling
por: Gambardella, Jessica, et al.
Publicado: (2020)

Metabolism and Chronic Inflammation: The Links Between Chronic Heart Failure and Comorbidities
por: Li, Zhiwei, et al.
Publicado: (2021)

Identification of decompensation episodes in chronic heart failure patients based solely on heart sounds
por: Susič, David, et al.
Publicado: (2022)

Effectiveness of β-blockers in physically active patients with hypertension: protocol of a systematic review
por: Tučková, Dagmar, et al.
Publicado: (2016)

Prolonged Postoperative Vasoplegia in Pediatric Patients on Chronic Angiotensin II Blocker Treatment
por: Pandya, Nischal R., et al.
Publicado: (2018)

β blockers for heart failure
por: Hoes, Arno W
Publicado: (2016)

Catecholamine Surges Cause Cardiomyocyte Necroptosis via a RIPK1–RIPK3-Dependent Pathway in Mice
por: Wu, Penglong, et al.
Publicado: (2021)

Unraveling the Metabolic Derangements Occurring in Non-infarcted Areas of Pig Hearts With Chronic Heart Failure
por: Correia, Cláudia, et al.
Publicado: (2021)

Phenotypic Presentations of Heart Failure Among Patients With Chronic Inflammatory Diseases
por: Underberg, Daniel L., et al.
Publicado: (2022)

Enhancing Palliative Care for Patients With Advanced Heart Failure Through Simple Prognostication Tools: A Comparison of the Surprise Question, the Number of Previous Heart Failure Hospitalizations, and the Seattle Heart Failure Model for Predicting 1-Year Survival
por: Blum, Moritz, et al.
Publicado: (2022)

Novel lncRNA-miRNA-mRNA Competing Endogenous RNA Triple Networks Associated Programmed Cell Death in Heart Failure
por: Zheng, Yu, et al.
Publicado: (2021)

Exercise-Based Rehabilitation Delivery Models in Comorbid Chronic Pulmonary Disease and Chronic Heart Failure
por: Borghi-Silva, Audrey, et al.
Publicado: (2021)

β-Adrenergic Receptor Desensitization/Down-Regulation in Heart Failure: A Friend or Foe?
por: Mahmood, Abrahim, et al.
Publicado: (2022)

Increased Catecholamine Levels and Inflammatory Mediators Alter Barrier Properties of Brain Microvascular Endothelial Cells in vitro
por: Ittner, Cora, et al.
Publicado: (2020)

Clinical tolerability of generic versus brand beta blockers in heart failure with reduced left ventricular ejection fraction: a retrospective cohort from heart failure clinic
por: Chanchai, Rattanachai, et al.
Publicado: (2018)

Development and Validation of a Risk Score in Chinese Patients With Chronic Heart Failure
por: Lin, Maoning, et al.
Publicado: (2022)

Mechanism of tonifying-kidney Chinese herbal medicine in the treatment of chronic heart failure
por: Chen, Lizhen, et al.
Publicado: (2022)

Editorial: Novelties in the Therapeutic Approaches for Chronic Heart Failure: Cardiovascular Targets and Beyond
por: Sorgente, Antonio, et al.
Publicado: (2022)

Benefits of Interventional Telemonitoring on Survival and Unplanned Hospitalization in Patients With Chronic Heart Failure
por: Galinier, Michel, et al.
Publicado: (2022)

Alteration of the gut microbiota and metabolite phenylacetylglutamine in patients with severe chronic heart failure
por: Zhang, Zhendong, et al.
Publicado: (2023)

Novelties in the pharmacological approaches for chronic heart failure: new drugs and cardiovascular targets
por: Correale, Michele, et al.
Publicado: (2023)

Chronic vagus nerve stimulation in patients with heart failure: challenge or failed translation?
por: Wu, Zhihong, et al.
Publicado: (2023)

Comparison of ivabradine plus β-blockers versus β-blocker therapy only
por: Aalbers, J
Publicado: (2010)

Safety of chronic high-dose calcium channel blockers exposure in children with pulmonary arterial hypertension
por: Wu, Yan, et al.
Publicado: (2022)

Myocardial Infarction After High-Dose Catecholamine Application—A Case Report From an Experimental Imaging Study
por: Beyhoff, Niklas, et al.
Publicado: (2020)

GENERATOR HEART FAILURE DataMart: An integrated framework for heart failure research
por: D’Amario, Domenico, et al.
Publicado: (2023)

Think-aloud study about the diagnosis of chronic heart failure in Belgian general practice
por: Smeets, Miek, et al.
Publicado: (2019)

Prognostic Value of Serum Galectin-3 in Chronic Heart Failure: A Meta-Analysis
por: Cheng, Zhendong, et al.
Publicado: (2022)

Comparative Efficacy of Medical Treatments for Chronic Heart Failure: A Network Meta-Analysis
por: Xiang, Boyang, et al.
Publicado: (2022)

A Meta-Analysis of Growth Differentiation Factor-15 and Prognosis in Chronic Heart Failure
por: Luo, Jin-Wen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kkdkhdr48qfu1irt48aid12bha